Cat. No. | Product name | CAS No. |
DC66634 | R707 Featured | |
DC66635 |
ofatumumab
Featured
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes. |
679818-59-8 |
DC66636 | Genefrontier patent anti-CD69 Featured | |
DC66637 | KHK-2898 Featured | |
DC66638 | CergutuzumAb Featured | |
DC66639 | Class III Featured | |
DC66640 |
IMAB027
Featured
IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6+ ovarian and testicular cancer cell lines. |
1650599-68-0 |
DC66641 | AB1-11 Featured | |
DC66642 | IM-301 Featured | |
DC66643 | lendalizumab Featured | |
DC66644 |
Nurulimab
Featured
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma. |
2168561-20-2 |
DC66645 | Epilactose Featured | 50468-56-9 |
DC66646 |
Dinotefuran UF
Featured
Dinotefuran UF is the deuterium labeled γ-Tocotrienol. γ-Tocotrienol is an active form of vitamin E |
457614-34-5 |
DC66647 |
ICA-1S
Featured
ICA-1S is a potent, specific inhibitor of Protein Kinase C-iota (PKC-ι), does not inhibit PKC-ζ, the closely related atypical PKC family member. |
90597-15-2 |
DC60638 |
Acid-degradable PEG Lipid (ADP-2k)
Featured
Acid-degradable PEG Lipid (ADP) composed of polyethylene glycol lipid is synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improves the performance of LNP-mRNA complexes in vitro and in vivo. |
|
DC60639 |
Acid-degradable Anionic Lipid (ADA)
Featured
Acid-degradable Anionic Lipid (ADA) composed of anionic lipid is synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improves the performance of LNP-mRNA complexes in vitro and in vivo. |
|
DC60640 |
LI-3948
Featured
LI-3948 is a blood-brain barrier penetrant inositol hexakisphosphate kinase (IP6K) inhibitor with IC50 of 16 nM and brain/plasma ratio of 1.3, respectively. |
|
DC66648 |
CP-LC-1143
Featured
Lipid CP-LC-1143 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity. |
3040859-45-5 |
DC66649 |
CP-LC-1254
Featured
Lipid CP-LC-1254 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity. |
3040859-52-4 |
DC66650 |
CP-LC-0729
Featured
Lipid CP-LC-0729 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity. |
3040858-60-1 |
DC66651 |
CP-LC-0743
Featured
Lipid CP-LC-0743 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity. |
3040858-73-6 |
DC66652 |
CP-LC-0867
Featured
Lipid CP-LC-0867 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity. |
3040858-96-3 |